Limován (Zopiclone)

Zopiclone acts as a positive allosteric modulator at the benzodiazepine binding site of GABA‑A receptors. By enhancing GABA‑mediated chloride influx, it increases neuronal inhibition, producing a calming effect that facilitates the initiation and maintenance of sleep.

The exact dose of Limován is determined by the prescribing clinician based on the patient’s age, medical history, and response to therapy. Typical adult regimens start with the lowest effective dose, taken shortly before bedtime, and are adjusted only under medical supervision.

Safety data for Zopiclone in pregnancy and lactation are limited, and the drug is generally avoided unless the potential benefit outweighs the risk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternative treatments with their healthcare provider.

To place an order, submit an enquiry on the Limován product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Limován (Zopiclone) belongs to the cyclopyrrolone class, offering a rapid onset of sleep with a relatively short half‑life. Compared with benzodiazepines such as temazepam, Zopiclone may have a lower risk of dependence but shares similar sedative properties and requires careful monitoring for misuse.

Limován tablets should be stored at ambient temperature, below 25 °C, in the original blister pack to protect from moisture and light. Keep the medication out of reach of children and do not use it after the expiry date printed on the packaging.

Limován is taken orally with a glass of water, preferably just before bedtime. Patients should ensure they have a full night (7‑8 hours) of sleep opportunity and avoid activities requiring alertness, such as driving, after taking the medication.

Serious risks include complex sleep behaviours (e.g., sleep‑walking, sleep‑driving), severe allergic reactions, and respiratory depression, especially when combined with other central nervous system depressants or alcohol. Patients should seek immediate medical attention if they experience unusual sleep activities or difficulty breathing.

Limován is contraindicated in individuals with severe hepatic impairment, untreated sleep apnea, a history of substance misuse, or known hypersensitivity to Zopiclone. It should also be avoided in patients taking strong CYP3A4 inhibitors without medical supervision.